Increased blood–brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases
暂无分享,去创建一个
B. T. Hawkins | T. F. Lundeen | H. Brooks | R. Egleton | B. Hawkins | K. M. Norwood | H. L. Brooks | R. D. Egleton | Tamara F Lundeen | Tamara F. Lundeen | Kristi M. Norwood
[1] A. Rossini,et al. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. , 1976, Science.
[2] T. Ueda,et al. Pravastatin suppresses the increase in matrix metalloproteinase-2 levels after acute myocardial infarction. , 2005, International journal of cardiology.
[3] S Rozen,et al. Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.
[4] V. Hruby,et al. Passage of a δ‐Opioid Receptor Selective Enkephalin, [d‐Penicillamine2,5]Enkephalin, Across the Blood‐Brain and the Blood‐Cerebrospinal Fluid Barriers , 1996, Journal of neurochemistry.
[5] M. Lorenzi,et al. Studies on the permeability of the blood-brain barrier in experimental diabetes , 2006, Diabetologia.
[6] J. Tarbell,et al. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. , 1998, Diabetes.
[7] T. Imaizumi,et al. Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy. , 2005, Current pharmaceutical design.
[8] G. Vrensen,et al. Blood–brain barrier integrity is unaltered in human brain cortex with diabetes mellitus , 2002, Brain Research.
[9] T. Davis,et al. The Blood-Brain Barrier/Neurovascular Unit in Health and Disease , 2005, Pharmacological Reviews.
[10] R. Egleton,et al. Nicotine increases in vivo blood–brain barrier permeability and alters cerebral microvascular tight junction protein distribution , 2004, Brain Research.
[11] P. Scheltens,et al. Risk of dementia in diabetes mellitus: a systematic review , 2006, The Lancet Neurology.
[12] A. Iwata,et al. Blood brain barrier destruction in hyperglycemic chorea in a patient with poorly controlled diabetes , 1999, Journal of the Neurological Sciences.
[13] G. Rosenberg,et al. Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[14] A. Betz,et al. Sucrose permeability of the blood-retinal and blood-brain barriers. Effects of diabetes, hypertonicity, and iodate. , 1986, Investigative ophthalmology & visual science.
[15] S. Rapoport,et al. Altered Blood‐Nerve Barrier Permeability to Small Molecules in Experimental Diabetes Mellitus , 1987, Journal of neuropathology and experimental neurology.
[16] J. Preston,et al. Permeability of the developing blood-brain barrier to 14C-mannitol using the rat in situ brain perfusion technique. , 1995, Brain research. Developmental brain research.
[17] S. Daskalopoulou,et al. Matrix Metalloproteinases and Diabetic Vascular Complications , 2005, Angiology.
[18] G. Davies-Jones,et al. Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. , 2000, Brain : a journal of neurology.
[19] R. Egleton,et al. Modulation of cerebral microvascular permeability by endothelial nicotinic acetylcholine receptors. , 2005, American journal of physiology. Heart and circulatory physiology.
[20] R. Couture,et al. Kinin receptors in pain and inflammation. , 2001, European journal of pharmacology.
[21] A. Mooradian,et al. Blood-Brain Barrier Choline Transport Is Reduced in Diabetic Rats , 1987, Diabetes.
[22] G. Rosenberg,et al. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. , 1998, Stroke.
[23] S. Feman,et al. Statins ameliorate endothelial barrier permeability changes in the cerebral tissue of streptozotocin-induced diabetic rats. , 2005, Diabetes.
[24] Matthew R. McReynolds,et al. Renal medullary gene expression in aquaporin-1 null mice. , 2005, American journal of physiology. Renal physiology.
[25] T. Davis,et al. Effects of hypoxia-reoxygenation on rat blood-brain barrier permeability and tight junctional protein expression. , 2003, American journal of physiology. Heart and circulatory physiology.
[26] M. Haas,et al. Diabetes-Related Changes in Rat Cerebral Occludin and Zonula Occludens-1 (ZO-1) Expression , 2002, Neurochemical Research.
[27] T. Golde,et al. Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice. , 2006, Journal of hepatology.
[28] S. Jacqueminet,et al. Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[29] N. Rakieten,et al. Studies on the diabetogenic action of streptozotocin (NSC-37917). , 1963, Cancer chemotherapy reports.
[30] N. Rakieten. Studies on the diabetogenic action of streptozotocin , 1963 .
[31] X (inbo) Li,et al. Expression of zonula occludens‐1 (ZO‐1) and the transcription factor ZO‐1‐associated nucleic acid‐binding protein (ZONAB)–MsY3 in glial cells and colocalization at oligodendrocyte and astrocyte gap junctions in mouse brain , 2005, The European journal of neuroscience.
[32] M. Fini,et al. Role for Matrix Metalloproteinase 9 after Focal Cerebral Ischemia: Effects of Gene Knockout and Enzyme Inhibition with BB-94 , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[33] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .
[34] K. Frei,et al. Occludin proteolysis and increased permeability in endothelial cells through tyrosine phosphatase inhibition. , 1999, Journal of cell science.
[35] R. Egleton,et al. Blood-brain barrier tight junctions are altered during a 72-h exposure to lambda-carrageenan-induced inflammatory pain. , 2002, American journal of physiology. Heart and circulatory physiology.
[36] W. Banks,et al. Effect of Diabetes Mellitus on the Permeability of the Blood–Brain Barrier to Insulin , 1997, Peptides.
[37] S. Haffner,et al. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? , 1990, JAMA.
[38] A. Alm,et al. Blood-ocular and blood-brain barrier function in streptozocin-induced diabetes in rats. , 1984, Archives of ophthalmology.
[39] J. Sowers,et al. Epidemiology of Diabetes , 2004, Journal of clinical pharmacology.
[40] K. Hamano,et al. HMG-CoA Reductase Inhibitors Reduce Matrix Metalloproteinase-9 Activity in Human Varicose Veins , 2005, European Surgical Research.
[41] P. McGuire,et al. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood–retinal barrier , 2005, Laboratory Investigation.
[42] D. Fishman,et al. Matrilysin (MMP‐7) promotes invasion of ovarian cancer cells by activation of progelatinase , 2005, International journal of cancer.
[43] M. Haas,et al. Astrocytic and neuronal biochemical markers in the sera of subjects with diabetes mellitus , 2004, Neuroscience Letters.
[44] M. Ristow,et al. Neurodegenerative disorders associated with diabetes mellitus , 2004, Journal of Molecular Medicine.
[45] Karen J. Ferguson,et al. Increased blood–brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging , 2003, Journal of neurology, neurosurgery, and psychiatry.
[46] Elisabetta Dejana,et al. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. , 2004, Physiological reviews.
[47] Giuseppe Pennisi,et al. Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease , 2005, Vascular medicine.
[48] G. d’Annunzio,et al. Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitus. , 2005, Diabetes research and clinical practice.
[49] D. Ray,et al. Reversible disruption of tight junction complexes in the rat blood‐brain barrier, following transitory focal astrocyte loss , 2004, Glia.